allo-APZ2-OTS clinical trials

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

This study is testing a new cell therapy (allo-APZ2-OTS) for people with Epidermolysis Bullosa (EB), a rare skin condition. We want to see if it's safe and helps improve the skin. Some people will receive the new treatment, while others will get a dummy treatment (placebo).